Avidity of anti-phospholipid antibodies in relation to their levels

Lenka Fialová; Oliver Kuchař; Milada Petráčková; Ivan Malbohan; Tomáš Zima

doi:10.5114/ceji.2020.97901

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

2/2020
vol. 45

Send email

Copy url:

abstract:

Original paper

Avidity of anti-phospholipid antibodies in relation to their levels

Lenka Fialová

¹

,

Oliver Kuchař

¹

,

Milada Petráčková

¹

,

Ivan Malbohan

¹

,

Tomáš Zima

¹

Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic

Cent Eur J Immunol 2020; 45 (2): 136-143

DOI: https://doi.org/10.5114/ceji.2020.97901

Online publish date: 2020/07/27

View full text Get citation

PlumX metrics:

Introduction
The heterogeneity of anti-phospholipid antibodies can be manifested not only in different antigenic specificities, but also in their avidities. The aim of the study was to investigate the relationship between anti-cardiolipin antibody (aCL) IgG avidities and levels within the range of their titres, from very low to high ones.

Material and methods
We analyzed 78 serum samples from 60 patients by ELISA with chaotropic agents, using urea concentration of 6 and 8 mol/l and single diluted serum samples. The changes of aCL levels and avidities were explored during a long-term follow-up in 14 patients.

Results
The avidities of aCLs did not differ in the groups of patients classified according to aCL levels. The higher avidity antibodies predominated in our patients and the fluctuation of avidities in the longitudinal follow-up did not show significant differences. No relationship between aCL levels and their avidities was found.

Conclusions
aCL avidities seem to have no relationship with aCL levels and high-avidity aCLs; the potentially deleterious effects might be present also in patients with low and extremely low aCL levels. Avidity of aCLs

keywords:

Avidity of anti-phospholipid antibodies in relation to their levels

Lenka Fialová 1 , Oliver Kuchař 1 , Milada Petráčková 1 , Ivan Malbohan 1 , Tomáš Zima 1

anti-cardiolipin antibodies, anti-phospholipid antibodies, avidity, ELISA, chaotropic agents, urea, thrombosis, systemic lupus erythematosus

Lenka Fialová

¹

,

Oliver Kuchař

¹

,

Milada Petráčková

¹

,

Ivan Malbohan

¹

,

Tomáš Zima

¹